Last reviewed · How we verify

NCT04358263: CORRIDA

Is Real-time CGM Superior to Flash Glucose Monitoring

Status unknown NA Last updated 28 April 2020
What this trial tests

NA trial testing Continuous Glucose Monitoring Guardian Connect Mobile system (real-time continuous glucose monitoring) in Diabetes Mellitus, Type 1 in 60 participants. Status unknown.

Timeline
1 September 2018
Primary endpoint
30 April 2019
30 November 2020

Quick facts

Lead sponsorCharles University, Czech Republic
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date1 September 2018
Primary completion30 April 2019
Estimated completion30 November 2020
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Charles University, Czech Republic

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the investigator's study is to compare real-time continuous glucose monitoring and flash glucose monitoring in adult patients with Type 1 Diabetes during 4-day training program focused on physical activity and over 4 weeks of follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A, Radovnická L, Petruželková L, Parkin CG, et al · · 2020 · cited 104× · PMID 32859607 · DOI 10.2337/dc20-0112

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

Other Charles University, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04358263.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing